On behalf of a medical device manufacturer that is self-insured for its product liability risk, our firm designed and developed a compliance policy to navigate the reporting requirements of Section 111 of MMSEA.
We created a Section 111 compliance program that was uniquely tailored to the self-insured entity's needs, and complemented the entity’s existing compliance program in a collaborative effort with existing complement of professionals.
In addition to creating and implementing the initial compliance program, we continue to manage the quarterly reporting process for the self-insured entity and provides counsel and assistance to the entity related to its claims, which includes mass tort and other uniquely structured settlements. Additionally, our firm monitors new developments with respect to the Section 111 laws and provides updates to the client if and when any changes in the law occur.
